Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery, DCL Ink Cancer Dx Collaboration

NEW YORK (GenomeWeb News) – Health Discovery Corporation has partnered with DCL Medical Laboratories to develop and commercialize DCL’s diagnostic tests for ovarian, cervical, and endometrial cancers.
 
Under the agreement, Savannah, Ga.-based HDC will own the developed intellectual property and DCL will have a sole-use license for applications and new mathematical tools that are developed over the course of the collaboration.
 
DCL’s support vector machine-based molecular diagnostic tests will be performed on digital images to help doctors provide more accurate diagnoses on biopsy and surgical specimens.
 
HDC is focused on SVM-based molecular diagnostic tests in genomics, proteomics, digital image analysis, and radiology.
 
Financial terms of the agreement were not released.

The Scan

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.